Blackstone Inc.

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1393818 NEW YORK, NY

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,193,187

-$7,067,674 QoQ

Shares Held

231,282

-51.5% QoQ

Ownership

0.200%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#96

of 316 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Blackstone Inc. holds $185,974,784 across 43 Biotechnology names. TERN ranks #4 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AUTL	Autolus Therapeutics plc	20,485,611	$28,270,143
2	SYRE	Spyre Therapeutics, Inc.	292,847	$14,771,202
3	DMRA	Damora Therapeutics, Inc.	503,522	$13,041,219
4	TERN	Terns Pharmaceuticals, Inc. This page	231,282	$12,193,187
5	TARA	Protara Therapeutics, Inc.	2,265,514	$11,803,327
6	ALXO	Alx Oncology Holdings Inc	5,826,544	$11,682,220
7	XFOR	X4 Pharmaceuticals, Inc	2,681,922	$11,076,337
8	IKT	Inhibikase Therapeutics, Inc.	5,938,276	$9,976,303

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,193,187	231,282	-51.5%	Shares	Other	2026-05-15
2025-12-31	$19,260,861	476,754	—	Shares	Other	2026-02-17
No filing history on record for this holder in this stock.